Drug intelligence / Profile preview

mephenoxalone

Development stage
Unknown
Lead developer
OM Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Mephenoxalone is a centrally acting skeletal muscle relaxant and mild anxiolytic belonging to the oxazolidinone chemical class. Introduced in the early 1960s, it is used to treat muscle spasms, tension, and associated anxiety. It is often described as a "myopsychic relaxant" due to its dual effect on physical muscle tone and psychological tension. Mephenoxalone has been studied and marketed both as a monotherapy and in combination with other agents, such as acetaminophen for pain or tridihexethyl for gastrointestinal conditions like duodenal ulcers. Its metabolism involves hydroxylation and demethylation, and it is primarily excreted in the urine.

Brand names
Control-OMDorsiflexXalylModeril
Other names
5-(o-methoxyphenoxymethyl)-2-oxazolidinonemephenoxalonum5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one

Beyond the preview

Go deeper on mephenoxalone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mephenoxalone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call